Trials / Completed
CompletedNCT03753737
Personality Disorders and Substance Use Disorders in a Sexual Context in the Man Having Sex With Other Men Population
A Study of the Relationship Between Personality Disorders and Substance Use Disorders in a Sexual Context in the Man Having Sex With Other Men Population - An Observational Study Based on a Cross-sectional Survey.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 94 (actual)
- Sponsor
- Hospices Civils de Lyon · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Chemsex refers to the use of psychoactive drugs in a sexual context, mainly cathinones, GHB/GBL, methamphetamine, cocaine and ketamine. This can cause infectious or psychiatric complications, addictions, and often goes with high risk sexual behaviours. Recent studies have highlighted the relationship between personality disorders, substance use disorders and risky sexual behaviours. It is important to understand the factors associated with chemsex in order to offer adapted prevention and care plans. The study hypothesis is that personality disorders, evaluated with the PDQ-4+ questionnaire, are more frequent among man having sex with other men with a substance use disorder linked to chemsex than among man having sex with other men who have never practised chemsex.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Questionnaires and semi-structured interview | * Questionnaires : PDQ-4+ (personality disorders), HAD (Anxiety and Depression), AUDIT-c (Alcohol consumption), CTQ-SF (Childhood Trauma Questionnaire). * Semi-structured interview : Evaluation of socio-demographic characteristics, psychiatric and addiction comorbidities, sexually transmitted infections, sexual practices, sexual dysfunction, hypersexual disorder. |
Timeline
- Start date
- 2018-11-22
- Primary completion
- 2019-04-29
- Completion
- 2019-04-29
- First posted
- 2018-11-27
- Last updated
- 2019-05-22
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03753737. Inclusion in this directory is not an endorsement.